Sign inJoin waitlistJoin the waitlist

SS

Stephen Sands

Director, Pediatric Neuropsychology Program · New York Presbyterian Hospital

Credentials: ·

History

New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
St. Luke’s-Roosevelt Medical Center
1996–1999
PsyD, New York University
Medical School
1992–1996

Research

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors
Journal of Clinical Oncology · 1998 · 180 citations
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols
Pediatric Blood & Cancer · 2008 · 172 citations
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
Neurosurgery · 2011 · 123 citations

JF
Jonathan Finlay
14 papers
Kara Kelly
9 papers
Lewis Silverman
9 papers
James Garvin
8 papers
SG
Sharon Gardner
8 papers
Peter Cole
7 papers
JA
Jeffrey Allen
6 papers
Jennifer Welch
6 papers
Abraham Bartell
5 papers
Justine Kahn
5 papers
Lisa Gennarini
5 papers
Girish Dhall
4 papers

Grants

Metformin to Prevent Chemotherapy-Induced Neurotoxicity Among Children with Leukemia
National Cancer Institute · R01
PI · $600.9K · Rutgers Biomedical and Health Sciences
2026–2031
Prospective International Phase-III Study to Improve Neurocognitive Outcomes in Young Children with Low-Risk Medulloblastoma (YCMB-LR)
National Cancer Institute · R01
Contact PI · $501K · Sloan-Kettering Inst Can Research
2023–2030
Identifying Children with Subclinical Neurocognitive Decline and Susceptibility to Oxidative Damage During the Early Months of Therapy for ALL
National Cancer Institute · R01
PI · $3.4M · Rutgers Biomedical and Health Sciences
2018–2024
Markers of Cognitive Decline During Treatment for Childhood ALL
National Cancer Institute · R21
PI · $412.1K · Albert Einstein College of Medicine, Inc
2015–2018

Clinical trials

Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2017–2027